Form 8K Bone Biologics Corp For: 30 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bone Biologics Corp (BBLG)
Bone Biologics Corp stock price live, this page displays NASDAQ BBLG stock exchange data. View the BBLG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bone Biologics Corp real time stock price chart below.
What Is the Bone Biologics Corp Stock Price Today?
The Bone Biologics Corp stock price today is 2.7300.
What Is the Stock Symbol for Bone Biologics Corp?
The stock symbol for Bone Biologics Corp is ""BBLG.""
What Stock Exchange Does Bone Biologics Corp Trade On?
Bone Biologics Corp is listed and trades on the NASDAQ stock exchange.
Is Bone Biologics Corp a Good Stock to Buy?
Determining whether Bone Biologics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BBLG quote. (ISIN: US0980706008)
What Is the Bone Biologics Corp Stock Price Today?
The Bone Biologics Corp stock price today is 2.7300.
What Is the Stock Symbol for Bone Biologics Corp?
The stock symbol for Bone Biologics Corp is ""BBLG.""
What Stock Exchange Does Bone Biologics Corp Trade On?
Bone Biologics Corp is listed and trades on the NASDAQ stock exchange.
Is Bone Biologics Corp a Good Stock to Buy?
Determining whether Bone Biologics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BBLG quote. (ISIN: US0980706008)
NASDAQ
Currency in USD
2.7300
0.0000(0.00%)
Real-time Data·
Fair Value
An estimate of a Bone Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6600
2.8000
52 wk Range
2.6500
16.5000
BBLG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BBLG is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Bone Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.66002.8000
52 wk Range
2.650016.5000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BBLG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bone Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Bone Biologics announces 1-for-6 reverse stock split
- Investing.com
- Form 8K Bone Biologics Corp For: 30 June
- Investing.com
- Form 8K Bone Biologics Corp For: 26 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Bone Biologics Corp Company Profile
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company’s NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Compare BBLG to Peers and Sector
Metrics to compare | BBLG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBBLGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −3.7x | −0.5x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price/Book | 1.5x | 3.3x | 2.6x | |
Price / LTM Sales | - | 166.2x | 3.3x | |
Upside (Analyst Target) | - | 127.0% | 45.1% | |
Fair Value Upside | Unlock | −1.3% | 7.4% | Unlock |
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.32 / -7.68
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Bone Biologics Trade On?
Bone Biologics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Bone Biologics?
The stock symbol for Bone Biologics is "BBLG."
What Is the Bone Biologics Market Cap?
As of today, Bone Biologics market cap is 4.38M.
What Is Bone Biologics's Earnings Per Share (TTM)?
The Bone Biologics EPS (TTM) is -20.88.
From a Technical Analysis Perspective, Is BBLG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bone Biologics Stock Split?
Bone Biologics has split 5 times.
How Many Employees Does Bone Biologics Have?
Bone Biologics has 2 employees.
What is the current trading status of Bone Biologics (BBLG)?
As of 04 Aug 2025, Bone Biologics (BBLG) is trading at a price of 2.73, with a previous close of 2.73. The stock has fluctuated within a day range of 2.66 to 2.80, while its 52-week range spans from 2.65 to 16.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.